(Q44403669)

2 December 2017

0 references

Of mice, men and nanoparticle biocoronas: are in vitro to in vivo correlations and interspecies extrapolations realistic? (English)

1 reference

2 December 2017

0 references

Jim E Riviere

1

1 reference

2 December 2017

publication date

1 September 2013

1 reference

2 December 2017

1 reference

2 December 2017

volume

8

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

1357-1359

1 reference

The nanoparticle–protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Understanding biophysicochemical interactions at the nano-bio interface

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Biomolecular coronas provide the biological identity of nanosized materials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Modeling the time evolution of the nanoparticle-protein corona in a body fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Theoretical versus empirical allometry: Facts behind theories and application to pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

Physiologically based pharmacokinetic modeling of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.13.129

21 January 2018

Identifiers

DOI

10.2217/NNM.13.129

1 reference

2 December 2017

1 reference